Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Comparative pharmacokinetics and pharmacodynamics of intravenous artelinate versus artesunate in uncomplicated Plasmodium coatneyi-infected rhesus monkey model.

Teja-Isavadharm P, Siriyanonda D, Rasameesoraj M, Limsalakpeth A, Chanarat N, Komcharoen N, Weina PJ, Saunders DL, Gettayacamin M, Scott Miller R.

Malar J. 2016 Sep 6;15:453. doi: 10.1186/s12936-016-1456-6.

2.

A simplified liquid chromatography-mass spectrometry assay for artesunate and dihydroartemisinin, its metabolite, in human plasma.

Teja-Isavadharm P, Siriyanonda D, Siripokasupkul R, Apinan R, Chanarat N, Lim A, Wannaying S, Saunders D, Fukuda MM, Miller RS, Weina PJ, Meléndez V.

Molecules. 2010 Dec 1;15(12):8747-68. doi: 10.3390/molecules15128747.

3.

Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.

Walsh DS, Wilairatana P, Tang DB, Heppner DG Jr, Brewer TG, Krudsood S, Silachamroon U, Phumratanaprapin W, Siriyanonda D, Looareesuwan S.

Clin Infect Dis. 2004 Oct 15;39(8):1095-103. Epub 2004 Sep 24.

PMID:
15486831
4.

Artemether bioavailability after oral or intramuscular administration in uncomplicated falciparum malaria.

Silamut K, Newton PN, Teja-Isavadharm P, Suputtamongkol Y, Siriyanonda D, Rasameesoraj M, Pukrittayakamee S, White NJ.

Antimicrob Agents Chemother. 2003 Dec;47(12):3795-8.

5.

Comparison of oral artesunate and dihydroartemisinin antimalarial bioavailabilities in acute falciparum malaria.

Newton PN, van Vugt M, Teja-Isavadharm P, Siriyanonda D, Rasameesoroj M, Teerapong P, Ruangveerayuth R, Slight T, Nosten F, Suputtamongkol Y, Looareesuwan S, White NJ.

Antimicrob Agents Chemother. 2002 Apr;46(4):1125-7.

Supplemental Content

Loading ...
Support Center